Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-25 @ 9:46 PM
Study NCT ID:
NCT01131351
Status:
TERMINATED
Last Update Posted:
2021-11-11
First Post:
2010-05-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-25
First Submit QC Date:
None
Study First Post Date:
2010-05-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-13
Results First Submit QC Date:
None
Results First Post Date:
2021-11-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-07-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-10-14
Last Update Post Date:
2021-11-11
Last Update Post Date Type:
ACTUAL